Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 38.65 ($0.49) and traded as high as GBX 40 ($0.51). Beximco Pharmaceuticals shares last traded at GBX 39 ($0.49), with a volume of 60,046 shares changing hands.
Beximco Pharmaceuticals Stock Down 1.3 %
The company has a current ratio of 1.80, a quick ratio of 0.37 and a debt-to-equity ratio of 14.73. The stock’s 50-day moving average price is GBX 38.65 and its 200-day moving average price is GBX 38.99. The company has a market cap of £173.98 million, a P/E ratio of 487.50 and a beta of 0.63.
About Beximco Pharmaceuticals
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.
Read More
- Five stocks we like better than Beximco Pharmaceuticals
- What is MarketRank™? How to Use it
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- How to invest in marijuana stocks in 7 steps
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.